Guidelines for imaging and staging of neuroblastic tumors: Consensus report from the international neuroblastoma risk group project

Radiology

Volumn 261, Issue 1, 2011, Pages 243-257

  Brisse, Hervé J ^a   McCarville, M Beth ^b   Granata, Claudio ^c   Krug, K Barbara ^d   Wootton Gorges, Sandra L ^e   Kanegawa, Kimio ^f   Giammarile, Francesco ^g   Schmidt, Matthias ^d   Shulkin, Barry L ^b   Matthay, Katherine K ^h,i   Lewington, Valerie J ^j   Sarnacki, Sabine ^k   Hero, Barbara ^d   Kaneko, Michio ^l   London, Wendy B ^m   Pearson, Andrew D J ⁿ   Cohn, Susan L ^o   Monclair, Tom ^p  

^a INSTITUT CURIE   (France)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c G GASLINI INSTITUTE   (Italy)

^d UNIVERSITY OF COLOGNE   (Germany)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f AICHI CHILDREN'S HEALTH AND MEDICAL CENTER   (Japan)

^g CENTRE HOSPITALIER LYON SUD   (France)

^h UNIVERSITY OF FLORIDA   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^k HÔPITAL NECKER ENFANTS MALADES   (France)

^l UNIVERSITY OF TSUKUBA   (Japan)

^m BOSTON CHILDREN S HOSPITAL   (United States)

ⁿ INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^o UNIVERSITY OF CHICAGO   (United States)

^p OSLO UNIVERSITY HOSPITAL   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

BONE MARROW METASTASIS; BONE METASTASIS; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONSENSUS; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; HEALTH CARE ORGANIZATION; HUMAN; IMAGE ANALYSIS; NEUROBLASTOMA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PATHOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; REPRODUCIBILITY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCINTIGRAPHY; STANDARDIZATION; TREATMENT PLANNING; TUMOR DIAGNOSIS; TUMOR LOCALIZATION;

CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; DIAGNOSTIC IMAGING; HUMANS; NEOPLASM METASTASIS; NEOPLASM STAGING; NEUROBLASTOMA; RISK FACTORS;

EID: 80053070127     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.11101352     Document Type: Review

References (63)

1. Pearson ADJ, Pinkerton R. Neuroblastoma. In: Pinkerton R, Plowman PN, Pieters R, eds. Paediatric oncology. London, England: Arnold, 2004;386-414.
2. Cohn SL, Pearson AD, London WB, et al. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol 2009;27(2):289-297.
3. Castleberry RP, Pritchard J, Ambros P, et al. The International Neuroblastoma Risk Groups (INRG): a preliminary report. Eur J Cancer 1997;33(12):2113-2116. (Pubitemid 28123466)
4. Woods WG, LaQuaglia MP. The drama of the gifted disease. J Clin Oncol 2009;27(2):172-173.
5. Shimada H, Umehara S, Monobe Y, et al. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group. Cancer 2001;92(9):2451-2461. (Pubitemid 33029092)
6. Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993;11(8):1466-1477. (Pubitemid 23228250)
7. Brodeur GM, Seeger RC, Barrett A, et al. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol 1988;6(12):1874-1881. (Pubitemid 19089071)
8. Monclair T, Brodeur GM, Ambros PF, et al. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol 2009;27(2):298-303.
9. Kushner BH, LaQuaglia MP, Kramer K, Cheung NK. Radically different treatment recommendations for newly diagnosed neuroblastoma: pitfalls in assessment of risk. J Pediatr Hematol Oncol 2004;26(1):35-39. (Pubitemid 38095633)
10. Siegel MJ, Jaju A. MR imaging of neuroblastic masses. Magn Reson Imaging Clin N Am 2008;16(3):499-513, vi. (Pubitemid 351862389)
11. McHugh K. Renal and adrenal tumours in children. Cancer Imaging 2007;7 : 41-51. (Pubitemid 47528072)
12. Mehta K, Haller JO, Legasto AC. Imaging neuroblastoma in children. Crit Rev Computed Tomogr 2003;44(1):47-61. (Pubitemid 36828287)
13. Lonergan GJ, Schwab CM, Suarez ES, Carlson CL. Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologicpathologic correlation. RadioGraphics 2002;22(4):911-934.
14. Hiorns MP, Owens CM. Radiology of neuroblastoma in children. Eur Radiol 2001;11(10):2071-2081. (Pubitemid 32936913)
15. Brisse H, Edeline V, Michon J, Couanet D, Zucker J, Neuenschwander S. Current strategy for the imaging of neuroblastoma [in French]. J Radiol 2001;82(4):447-454. (Pubitemid 32428212)
16. Sofka CM, Semelka RC, Kelekis NL, et al. Magnetic resonance imaging of neuroblastoma using current techniques. Magn Reson Imaging 1999;17(2):193-198. (Pubitemid 29053177)
17. Berdon WE, Ruzal-Shapiro C, Abramson SJ, Garvin J. The diagnosis of abdominal neuroblastoma: relative roles of ultrasonography, CT, and MRI. Urol Radiol 1992;14(4):252-262. (Pubitemid 23121552)
18. Wu YH, Song B, Xu J, et al. Retroperitoneal neoplasms within the perirenal space in infants and children: differentiation of renal and non-renal origin in enhanced CT images. Eur J Radiol 2010;75(3):279-286.
19. Abramson SJ, Berdon WE, Stolar C, Ruzal-Shapiro C, Garvin J. Stage IVN neuroblastoma: MRI diagnosis of left supraclavicular "Virchow's" nodal spread. Pediatr Radiol 1996;26(10):717-719. (Pubitemid 26333963)
20. Siegel MJ, Ishwaran H, Fletcher BD, et al. Staging of neuroblastoma at imaging: report of the radiology diagnostic oncology group. Radiology 2002;223(1):168-175. (Pubitemid 34258205)
21. Brody AS, Frush DP, Huda W, Brent RL; American Academy of Pediatrics Section on Radiology. Radiation risk to children from computed tomography. Pediatrics 2007;120(3):677-682. (Pubitemid 47358314)
22. Gatcombe HG, Marcus RB Jr, Katzenstein HM, Tighiouart M, Esiashvili N. Excellent local control from radiation therapy for high-risk neuroblastoma. Int J Radiat Oncol Biol Phys 2009;74(5):1549-1554.
23. Jonsson JH, Karlsson MG, Karlsson M, Nyholm T. Treatment planning using MRI data: an analysis of the dose calculation accuracy for different treatment regions. Radiat Oncol 2010;5:62.
24. Kornreich L, Horev G, Kaplinsky C, Ziv N, Grünebaum M. Neuroblastoma: evaluation with contrast enhanced MR imaging. Pediatr Radiol 1991;21(8):566-569.
25. Sauvat F, Brisse H, Magdeleinat P, et al. The transmanubrial approach: a new operative approach to cervicothoracic neuroblastoma in children. Surgery 2006;139(1):109-114. (Pubitemid 41814439)
26. Squire R, Sarnacki S, Haider N, Gerrard M, Rubie H, Michon J. The outcome of surgical procedures at diagnosis in localised infant neuroblastoma and the effect of chemotherapy on resectability: European Infant Neuroblastoma Study [abstr]. Pediatr Blood Cancer 2007;49:402.
27. Maris JM, Kyemba SM, Rebbeck TR, et al. Molecular genetic analysis of familial neuroblastoma. Eur J Cancer 1997;33(12):1923-1928. (Pubitemid 28123426)
28. Hiyama E, Yokoyama T, Hiyama K, et al. Multifocal neuroblastoma: biologic behavior and surgical aspects. Cancer 2000;88(8):1955-1963. (Pubitemid 30213007)
29. Boglino C, Martins AG, Ciprandi G, Sousinha M, Inserra A. Spinal cord vascular injuries following surgery of advanced thoracic neuroblastoma: an unusual catastrophic complication. Med Pediatr Oncol 1999;32(5):349-352. (Pubitemid 29196283)
30. Cecchetto G, Mosseri V, De Bernardi B, et al. Surgical risk factors in primary surgery for localized neuroblastoma: the LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group. J Clin Oncol 2005;23(33):8483-8489.
31. Shamberger RC, Smith EI, Joshi VV, et al. The risk of nephrectomy during local control in abdominal neuroblastoma. J Pediatr Surg 1998;33(2):161-164. (Pubitemid 28093691)
32. Berdon WE, Stylianos S, Ruzal-Shapiro C, Hoffer F, Cohen M. Neuroblastoma arising from the organ of Zuckerkandl: an unusual site with a favorable biologic outcome. Pediatr Radiol 1999;29(7):497-502. (Pubitemid 29304205)
33. DuBois SG, Kalika Y, Lukens JN, et al. Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival. J Pediatr Hematol Oncol 1999;21(3):181-189. (Pubitemid 30306028)
34. Matthay KK, Shulkin B, Ladenstein R, et al. Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force. Br J Cancer 2010;102(9):1319-1326.
35. Olivier P, Colarinha P, Fettich J, et al. Guidelines for radioiodinated MIBG scintigraphy in children. Eur J Nucl Med Mol Imaging 2003;30(5):B45-B50.
36. Franzius C, Schmidt M, Hero B, Pfluger T, Hahn K. Procedure guidelines for MIBG-scintigraphy in children [in German]. Nuklearmedizin 2008;47(3):132-138. (Pubitemid 351881409)
37. Lumbroso J, Guermazi F, Hartmann O, et al. Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases [in French]. Bull Cancer 1988;75(1):97-106. (Pubitemid 18050467)
38. Jacobs A, Delree M, Desprechins B, et al. Consolidating the role of*I-MIBG-scintigraphy in childhood neuroblastoma: five years of clinical experience. Pediatr Radiol 1990;20(3):157-159. (Pubitemid 20044501)
39. Gelfand MJ, Elgazzar AH, Kriss VM, Masters PR, Golsch GJ. Iodine-123-MIBG SPECT versus planar imaging in children with neural crest tumors. J Nucl Med 1994;35(11):1753-1757. (Pubitemid 24346793)
40. Rozovsky K, Koplewitz BZ, Krausz Y, et al. Added value of SPECT/CT for correlation of MIBG scintigraphy and diagnostic CT in neuroblastoma and pheochromocytoma. AJR Am J Roentgenol 2008;190(4):1085-1090. (Pubitemid 351571524)
41. Rufini V, Shulkin B. The evolution in the use of MIBG in more than 25 years of experimental and clinical applications. Q J Nucl Med Mol Imaging 2008;52(4):341-350.
42. Shulkin BL, Hutchinson RJ, Castle VP, Yanik GA, Shapiro B, Sisson JC. Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy- D-glucose compared with metaiodobenzylguanidine scintigraphy. Radiology 1996;199(3):743-750.
43. Kaufman RA, Thrall JH, Keyes JW Jr, Brown ML, Zakem JF. False negative bone scans in neuroblastoma metastatic to the ends of long bones. AJR Am J Roentgenol 1978;130(1):131-135. (Pubitemid 8259596)
44. De Bernardi B, Gerrard M, Boni L, et al. Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification. J Clin Oncol 2009;27(7):1034-1040.
45. Sharp SE, Shulkin BL, Gelfand MJ, Salisbury S, Furman WL. 123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma. J Nucl Med 2009;50(8):1237-1243.
46. Taggart DR, Han MM, Quach A, et al. Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma. J Clin Oncol 2009;27(32):5343-5349.
47. Mazumdar A, Siegel MJ, Narra V, Luchtman-Jones L. Whole-body fast inversion recovery MR imaging of small cell neoplasms in pediatric patients: a pilot study. AJR Am J Roentgenol 2002;179(5):1261-1266. (Pubitemid 35204384)
48. Kellenberger CJ, Epelman M, Miller SF, Babyn PS. Fast STIR whole-body MR imaging in children. RadioGraphics 2004;24(5):1317-1330. (Pubitemid 39329377)
49. Meyer JS, Siegel MJ, Farooqui SO, Jaramillo D, Fletcher BD, Hoffer FA. Which MRI sequence of the spine best reveals bone-marrow metastases of neuroblastoma? Pediatr Radiol 2005;35(8):778-785. (Pubitemid 41131178)
50. Daldrup-Link HE, Franzius C, Link TM, et al. Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET. AJR Am J Roentgenol 2001;177(1):229-236. (Pubitemid 32578088)
51. Goo HW, Choi SH, Ghim T, Moon HN, Seo JJ. Whole-body MRI of paediatric malignant tumours: comparison with conventional oncological imaging methods. Pediatr Radiol 2005;35(8):766-773. (Pubitemid 41131176)
52. Schmidt GP, Reiser MF, Baur-Melnyk A. Whole-body MRI for the staging and follow-up of patients with metastasis. Eur J Radiol 2009;70(3):393-400.
53. Darge K, Jaramillo D, Siegel MJ. Wholebody MRI in children: current status and future applications. Eur J Radiol 2008;68(2):289-298.
54. Jacobs MA, Pan L, Macura KJ. Whole-body diffusion-weighted and proton imaging: a review of this emerging technology for monitoring metastatic cancer. Semin Roentgenol 2009;44(2):111-122.
55. Uhl M, Altehoefer C, Kontny U, Il'yasov K, Büchert M, Langer M. MRI-diffusion imaging of neuroblastomas: first results and correlation to histology. Eur Radiol 2002;12(9):2335-2338. (Pubitemid 36940334)
56. Dubois SG, London WB, Zhang Y, et al. Lung metastases in neuroblastoma at initial diagnosis: a report from the International Neuroblastoma Risk Group (INRG) project. Pediatr Blood Cancer 2008;51(5):589-592.
57. Kammen BF, Matthay KK, Pacharn P, Gerbing R, Brasch RC, Gooding CA. Pulmonary metastases at diagnosis of neuroblastoma in pediatric patients: CT findings and prognosis. AJR Am J Roentgenol 2001;176(3):755-759. (Pubitemid 32181981)
58. Matthay KK, Brisse H, Couanet D, et al. Central nervous system metastases in neuroblastoma: radiologic, clinical, and biologic features in 23 patients. Cancer 2003;98(1):155-165. (Pubitemid 36741138)
59. D'Ambrosio N, Lyo JK, Young RJ, Haque SS, Karimi S. Imaging of metastatic CNS neuroblastoma. AJR Am J Roentgenol 2010;194(5):1223-1229.
60. Aronson MR, Smoker WR, Oetting GM. Hemorrhagic intracranial parenchymal metastases from primary retroperitoneal neuroblastoma. Pediatr Radiol 1995;25(4):284-285.
61. Kellie SJ, Hayes FA, Bowman L, et al. Primary extracranial neuroblastoma with central nervous system metastases characterization by clinicopathologic findings and neuroimaging. Cancer 1991;68(9):1999-2006.
62. Quackenbush KE, Luna-Fineman S, Magee JF, et al. Neuroblastoma involvement of the falx cerebri. Pediatr Blood Cancer 2009;53(7):1337-1339.
63. Lau JJ, Trobe JD, Ruiz RE, et al. Metastatic neuroblastoma presenting with binocular blindness from intracranial compression of the optic nerves. J Neuroophthalmol 2004;24(2):119-124. (Pubitemid 38720667)